Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00519142

Public ClinicalTrials.gov record NCT00519142. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Rapid Onset and Short Duration Insulin Secretogogue, Mitiglinide, in Combination With Metformin Versus Metformin Alone in Patients With Type 2 Diabetes Mellitus: A Randomized, Double-blind, Placebo-controlled Trial for 6 Months

Study identification

NCT ID
NCT00519142
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Elixir Pharmaceuticals
Industry
Enrollment
367 participants

Conditions and interventions

Interventions

  • placebo for mitiglinide Drug
  • mitiglinide Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Sep 30, 2008
Completion
Sep 30, 2008
Last update posted
Sep 16, 2009

2007 – 2008

United States locations

U.S. sites
57
U.S. states
21
U.S. cities
57
Facility City State ZIP Site status
Elixir Study Site Glendale Arizona
Elixir Study Site Greenbrae California
Elixir Study Site La Jolla California
Elixir Study Site Los Angeles California
Elixir Study Site Los Gatos California
Elixir Study Site(s) Oakland Area California
Elixir Study Site Orange California
Elixir Study Site West Hills California 91307
Elixir Study Site Westlake Village California
Elixir Study Site Pueblo Colorado
Elixir Study Site(s) Washington D.C. District of Columbia
Elixir Study Site Chiefland Florida 32626
Elixir Study Site Coral Gables Florida
Elixir Study Site Kissimmee Florida
Elixir Study Site(s) Miami Florida
Elixir Study Site Saint Cloud Florida
Elixir Study Site Winter Park Florida
Elixir Study Site Atlanta Georgia 30080
Elixir Study Site Austell Georgia
Elixir Study Site Perry Georgia
Elixir Study Site(s) Chicago Illinois
Elixir Study Site Wichita Kansas
Elixir Study Site Kansas City Missouri 64132
Elixir Study Site St Louis Missouri 63110
Elixir Study Site Las Vegas Nevada
Elixir Study Site Hamilton New Jersey
Elixir Study Site Hillsborough New Jersey
Elixir Study Site Sewell New Jersey
Elixir Study Site(s) New York New York
Elixir Study Site Mooresville North Carolina
Elixir Study Site Morehead City North Carolina
Elixir Study Site Akron Ohio
Elixir Study Site Cincinnati Ohio
Elixir Study Site Gallipolis Ohio
Elixir Study Site Kettering Ohio
Elixir Study Site Medford Oregon
Elixir Study Site Harleysville Pennsylvania
Elixir Study Site Levittown Pennsylvania
Elixir Study Site Uniontown Pennsylvania
Elixir Study Site Columbia South Carolina
Elixir Study Site Simpsonville South Carolina
Elixir Study Site Memphis Tennessee
Elixir Study Site Tullahoma Tennessee
Elixir Study Site(s) Dallas Texas
Elixir Study Site El Paso Texas
Elixir Study Site(s) Fort Worth Texas
Elixir Study Site(s) Houston Texas
Elixir Study Site Humble Texas
Elixir Study Site Midland Texas
Elixir Study Site New Braunfels Texas
Elixir Study Site North Richland Hills Texas
Elixir Study Site Pearland Texas
Elixir Study Site Plano Texas 75074
Elixir Study Site(s) San Antonio Texas
Elixir Study Site Temple Texas
Elixir Study Site Norfolk Virginia
Elixir Study Site Federal Way Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00519142, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 16, 2009 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00519142 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →